| Reference |
|---|
Pozzo E, Yedigaryan L, Giarratana N, Wang C, Garrido G, Degreef E, et al. miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma. Cell Rep. 2025;44:115171 pubmed publisher |
Ji X, Sun Z, Wu H, Zhang J, Liu S, Cao X, et al. More powerful dysregulation of Helicobacter pylori East Asian-type CagA on intracellular signalings. BMC Microbiol. 2024;24:467 pubmed publisher |
Huber A, Allam A, Dijkstra C, Thiem S, Huynh J, Poh A, et al. Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines. Cell Rep. 2024;43:114616 pubmed publisher |
Lim S, J F van Son G, Wisma Eka Yanti N, Andersson Rolf A, Willemsen S, Korving J, et al. Derivation of functional thymic epithelial organoid lines from adult murine thymus. Cell Rep. 2024;43:114019 pubmed publisher |
Alieva M, Barrera Rom xe1 n M, de Blank S, Petcu D, Zeeman A, Dautzenberg N, et al. BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response. Nat Protoc. 2024;19:2052-2084 pubmed publisher |
Kang S, Oh S, Lee K, Lee H, Kim M, Kwon T, et al. Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma via miR-876-3p. Theranostics. 2024;14:460-479 pubmed publisher |
Nzigou Mombo B, Bijonowski B, Raab C, Niland S, Brockhaus K, M xfc ller M, et al. Reversible photoregulation of cell-cell adhesions with opto-E-cadherin. Nat Commun. 2023;14:6292 pubmed publisher |
Strelez C, Perez R, Chlystek J, Cherry C, Yoon A, Haliday B, et al. Integration of Patient-Derived Organoids and Organ-on-Chip Systems: Investigating Colorectal Cancer Invasion within the Mechanical and GABAergic Tumor Microenvironment. bioRxiv. 2023;: pubmed publisher |
Pesce E, Cordiglieri C, Bombaci M, Eppenberger Castori S, Oliveto S, Manara C, et al. TMEM123 a key player in immune surveillance of colorectal cancer. Front Immunol. 2023;14:1194087 pubmed publisher |
de Vries N, van de Haar J, Veninga V, Chalabi M, Ijsselsteijn M, van der Ploeg M, et al. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature. 2023;613:743-750 pubmed publisher |
Vizoso M, E J Pritchard C, Bombardelli L, van den Broek B, Krimpenfort P, Beijersbergen R, et al. A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing. Nat Commun. 2022;13:6442 pubmed publisher |
Adnani L, Kassouf J, Meehan B, Spinelli C, Tawil N, Nakano I, et al. Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells. Nat Commun. 2022;13:5494 pubmed publisher |
Meister M, Groot Koerkamp M, de Souza T, Breunis W, Frazer Mendelewska E, Brok M, et al. Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes. EMBO Mol Med. 2022;14:e16001 pubmed publisher |
Jaykumar A, Plumber S, Barry D, Binns D, Wichaidit C, Grzemska M, et al. WNK1 collaborates with TGF-β in endothelial cell junction turnover and angiogenesis. Proc Natl Acad Sci U S A. 2022;119:e2203743119 pubmed publisher |
Margarido A, Uceda Castro R, Hahn K, de Bruijn R, Kester L, Hofland I, et al. Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases. Cancers (Basel). 2022;14: pubmed publisher |
Ek F, Blom K, Selvin T, Rudfeldt J, Andersson C, Senkowski W, et al. Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma. Sci Rep. 2022;12:8943 pubmed publisher |
Tavares S, Liv N, Pasolli M, Opdam M, R xe4 tze M, Saornil M, et al. FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer. Cell Rep. 2022;39:110584 pubmed publisher |
Sharma K, Thacker V, Dhar N, Clap xe9 s Cabrer M, Dubois A, Signorino Gelo F, et al. Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid model. Cell Rep. 2021;36:109351 pubmed publisher |
Krotenberg Garcia A, Fumagalli A, Le H, Jackstadt R, Lannagan T, Sansom O, et al. Active elimination of intestinal cells drives oncogenic growth in organoids. Cell Rep. 2021;36:109307 pubmed publisher |
Lõhmussaar K, Oka R, Espejo Valle Inclan J, Smits M, Wardak H, Korving J, et al. Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer. Cell Stem Cell. 2021;28:1380-1396.e6 pubmed publisher |
Dekkers J, van Vliet E, Sachs N, Rosenbluth J, Kopper O, Rebel H, et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat Protoc. 2021;16:1936-1965 pubmed publisher |
Mykytyn A, Breugem T, Riesebosch S, Schipper D, van den Doel P, Rottier R, et al. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. elife. 2021;10: pubmed publisher |
Hendriks D, Artegiani B, Hu H, Chuva de Sousa Lopes S, Clevers H. Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver. Nat Protoc. 2021;16:182-217 pubmed publisher |
Driehuis E, Kretzschmar K, Clevers H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc. 2020;15:3380-3409 pubmed publisher |
Fumagalli A, Oost K, Kester L, Morgner J, Bornes L, Bruens L, et al. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell Stem Cell. 2020;26:569-578.e7 pubmed publisher |
Gimeno Valiente F, Riffo Campos Á, Ayala G, Tarazona N, Gambardella V, Rodriguez F, et al. EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness. Sci Rep. 2020;10:3723 pubmed publisher |
Goldhammer N, Kim J, Timmermans Wielenga V, Petersen O. Characterization of organoid cultured human breast cancer. Breast Cancer Res. 2019;21:141 pubmed publisher |
Medina Echeverz J, Hinterberger M, Testori M, Geiger M, Giessel R, Bathke B, et al. Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies. Nat Commun. 2019;10:5041 pubmed publisher |
Driehuis E, Spelier S, Beltrán Hernández I, de Bree R, M Willems S, Clevers H, et al. Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy. J Clin Med. 2019;8: pubmed publisher |
Klueh U, Ludzinska I, Czajkowski C, Qiao Y, Kreutzer D. Crosslinked basement membrane-based coatings enhance glucose sensor function and continuous glucose monitoring in vivo. J Biomed Mater Res A. 2018;106:7-16 pubmed publisher |
